Noblegen opens new facility, targets global bioproducts markets
May 3, 2017 - Ontario bioproducts company Noblegen is expanding its marketing activities and looking to sell its algae-based bioproducts on a global scale. Noblegen has secured $1.8 million to target the global nutritional supplements and animal nutrition markets.
May 3, 2017 By Maria Church
Noblegen opened its new Gen 1 production facility, the largest commercial manufacturing facility of its kind in North America, in Peterborough, Ont., on March 31. The facility sustainably grows algae that can be used to create bioproducts, such as plant-based proteins and oils.
FedDev Ontario is contributing $600,000 for Noblegen’s scale up, which tops up $1.2 million from an accredited member of the Peterborough Region Angel Network.
“While we have developed naturally-inspired products to address significant industrial challenges, we must now determine how we can get these products to market,” Adam Noble, founder and CEO of Noblegen Inc., said in a news release. “The contribution from the Government of Canada, through FedDev Ontario, will allow us to get our sustainable products into the hands of the largest global actors, creating local employment in Canada, while helping to preserve our planet.”
Print this page